|
OALib Journal期刊
ISSN: 2333-9721
费用：99美元
|
|
|
|
固体药物的转晶现象
, PP. 521-527
Keywords: 药物稳定性,多晶型,转晶
Abstract:
在药物开发过程中,有些药物的稳定晶型可能会存在某些缺陷,如溶解度太差等,从而不得不考虑将一些动力学上可以稳定存在的亚稳晶型作为药用晶型开发上市。使用亚稳晶型存在晶型转变的风险。对固体药物转晶现象的研究可以帮助这些使用亚稳晶型的药物选择合适的生产和储存条件,避免因转晶而获得不需要的晶型。
| [1] | hilfikerr.polymorphisminthepharmaceuticalindustry[m].weinheim:wiley-vchverlaggmbh&co.kgaa,2006:218.
|
| [2] | kumarss,nangiaa.asolubilitycomparisonofneutralandzwitterionicpolymorphs[j].crystgrowthdes,2014,14:1865-1881.
|
| [3] | aldawsarih,altafa,banjarzm,etal.crystallizationofanewpolymorphofacetohexamidefrom2-hydroxybutyl-β-cyclodextrinsolution:formviwithahighaqueoussolubility[j].intjpharm,2013,453:315-321.
|
| [4] | pudipeddim,serajuddinatm.trendsinsolubilityofpolymorphs[j].jpharmsci,2005,94:929-939.
|
| [5] | bonfilior,lealjs,santosomm,etal.analysisofchlorthalidonepolymorphsinrawmaterialsandtabletsandtheeffectofformsiandiionthedissolutionpropertiesofdrugproducts[j].jpharmbiomedanal,2014,88:562-570.
|
| [6] | liuc,danglp,tongy,etal.influenceofpolymorphsonthetransformationwateractivityoftheophylline[j].indengchemres,2013,52:14979-14983.
|
| [7] | orolal,veidismv,sarcevicai,etal.theeffectofphonpolymorphformationofthepharmaceuticallyactivecompoundtianeptine[j].intjpharm,2012,432:50-56.
|
| [8] | anjh,choigj,kimws.polymorphicandkineticinvestigationofadefovirdipivoxilduringphasetransformation[j].intjpharm,2012,422:185-193.
|
| [9] | matsumotot,ichikawaji,kaneniwan,etal.effectofenvironmentaltemperatureonthepolymorphictransformationofphenylbutazoneduringgrinding[j].chempharmbull,1988,36:1074-1085.
|
| [10] | traskav,shann,motherwellwds,etal.selectivepolymorphtransformationviasolvent-dropgrinding[j].chemcommun(camb),2005,(7):880-882.
|
| [11] | takahashiy,nakashimak,ishiharat,etal.polymorphismoffostedil:chracterizationandpolymophicchangebymechanicaltreatments[j].drugdevindpharm,1985,11:1543-1563.
|
| [12] | lefebvrec,guyothermannam,draguetbrughmansm,etal.polymorphictransitionsofcarbamazepineduringgrindingandcompression[j].drugdevindpharm,1986,12:1913-1927.
|
| [13] | boldyrevaev.combinedx-raydiffractionandramanspectroscopystudiesofphasetransitionsincrystallineaminoacidsatlowtemperaturesandhighpressures:selectedexamples[j].phasetransitions,2009,82:303-321.
|
| [14] | barriom,maccaronie,rietveldib,etal.pressure-temperaturestatediagramforthephaserelationshipsbetweenbenfluorexhydrochlorideformsiandii:acaseofenantiotropicbehavior[j].jpharmsci,2012,101:1073-1078.
|
| [15] | xuj,pingqn,liugj.studiesonthecharacteristicsofpolymorphsofmetoclopramide[j].jchinpharmuniv(中国药科大学学报),1996,27:722-725.
|
| [16] | yuanhj,chendw,reng,etal.conversionconditionsandinfluencefactorsofnitrendipinecrystalpolymorphism[j].actachimsin(化学学报),2008,66:2429-2433.
|
| [17] | grooffd,liebenbergw,devilliersmm.preparationandtransformationoftruenifedipinepolymorphs:investigatedwithdifferentialscanningcalorimetryandx-raydiffractionpatternfittingmethods[j].jpharmsci,2011,100:1944-1957.
|
| [18] | sonoday,hirayamaf,arimah,etal.selectivecrystallizationofthemetastableformivpolymorphoftolbutamideinthepresenceof2,6-di-o-methyl-β-cyclodextrininaqueoussolution[j].crystgrowthdes,2006,6:1181-1185.
|
| [19] | ishigurot,hirayamaf,ioharad,etal.crystallizationandpolymorphictransitionsofchlorpropamideinaqueous2-hydroxybutyl-β-cyclodextrinsolution[j].eurjpharmsci,2010,39:248-255.
|
| [20] | kogawaac,salgadohrn.developmentandvalidationofinfraredspectroscopymethodforthedeterminationofdarunavirintablets[j].physchem,2013,3:1-6.
|
| [21] | araya-sibajaam,paulinoas,raubergs,etal.dissolutionproperties,solid-statetransformationandpolymorphiccrystallization:progesteronecasestudy[j].pharmdevtechnol,2014,19:779-788.
|
| [22] | silvaapc,meneghinilz,bajerskil,etal.discriminatorydissolutiontestfortabletscontainingalpha-andbeta-thalidomidepolymorphs[j].dissoluttechnol,2013,20:19-25.
|
| [23] | yuanhj,chendw,reny,etal.studyonpharmacokineticsandbioavailabilityofnirendipinecrystalpolymorphsinrabbits[j].chinhosppharmj(中国医院药学杂志),2009,29:29-32.
|
| [24] | yuanhj,chendw,liuyl,etal.studyonpharmacokineticsofnimodipinepolymorphsinrabbits[j].chinpharmj(中国药学杂志),2005,40:609-612.
|
| [25] | kobayashiy,itos,itais,etal.physicochemicalpropertiesandbioavailabilityofcarbamazepinepolymorphsanddihydrate[j].intjpharm,2000,193:137-146.
|
| [26] | yangc,rentk,wangj,etal.thermodynamicstabilityanalysisofm-nisoldipinepolymorphs[j].jchemthermodyn,2013,58:300-306.
|
| [27] | wangjr,wangxj,luly,etal.highlycrystallineformsofvalsartanwithsuperiorphysicochemicalstability[j].crystgrowthdes,2013,13:3261-3269.
|
| [28] | upadhyayp,dantuluriak,kumarl,etal.estimatingrelativestabilityofpolymorphsbygenerationofconfigurationalfreeenergyphasediagram[j].jpharmsci,2012,101:1843-1851.
|
| [29] | khomaneks,bansalak.differentialcompactionbehaviourofrollercompactedgranulesofclopidogrelbisulphatepolymorphs[j].intjpharm,2014,472:288-295.
|
| [30] | khomaneks,morepk,raghavendrag,etal.molecularunderstandingofthecompactionbehaviorofindomethacinpolymorphs[j].molpharm,2013,10:631-639.
|
| [31] | perumallasr,shilm,suncc.ionizedformofacetaminophenwithimprovedcompactionproperties[j].crystengcomm,2012,14:2389-2390.
|
| [32] | chengm.polymorphismofchloramphenicolpalmitate[j].chinpharmbull(药学通报),1982,17:29-32.
|
| [33] | zhangmf,guym,daizy.studiesonthebloodconcentrationsofdifferentpreparationsofchloramphenicolpalmitate[j].actaacadmedprimshanghai(上海第一医学院学报),1979,6:409-413.
|
| [34] | zhangq,luly,daiwj,etal.newpolymorphsofhuperzinea:preparation,structures,andphysicochemicalpropertiesofanhydrouscrystalforms[j].crystgrowthdes,2013,13:2198-2207.
|
| [35] | mahera,crokerdm,seatoncc,etal.solution-mediatedpolymorphictransformation:formiitoformiiipiracetaminorganicsolvents[j].crystgrowthdes,2014,14:3967-3974.
|
| [36] | zhangg,gaolp,zhangzx,etal.heating-inducedphasetransitionofbupropionhydrobromidepolymorphs[j].jpharmsci,2012,101:3091-3095.
|
| [37] | chanhk,doelkere.polymorphictransformationofsomedrugsundercompression[j].drugdevindpharm,1985,11:315-332.
|
| [38] | otsukam,kaneniwan.effectofseedcrystalsonsolid-statetransformationofpolymorphsofchloramphenicolpalmitateduringgrinding[j].jpharmsci,1986,75:506-511.
|
| [39] | berzinsa,actinsa,kreismanisjp.hydrationanddehydrationkineticsofxylazinehydrochloride[j].pharmdevtechnol,2009,14:388-399.
|
| [40] | crispjl,dannse,edgarm,etal.theeffectofparticlesizeonthedehydration/rehydrationbehaviouroflactose[j].intjpharm,2010,391:38-47.
|
| [41] | kangf,vogtfg,brumj,etal.effectofparticlesizeandmorphologyonthedehydrationmechanismofanon-stoichiometrichydrate[j].crystgrowthdes,2012,12:60-74.
|
| [42] | daveyrj,guypd,ruddickaj.theiv-iiipolymorphicphasetransitioninaqueousslurriesofammoniumnitrate[j].jcolloidinterfacesci,1985,108:189-192.
|
| [43] | grecok,bognerr.solution-mediatedphasetransformation:significanceduringdissolutionandimplicationsforbioavailability[j].jpharmsci,2012,101:2996-3018.
|
| [44] | kraljd,brecevicl,kontrecj.vateritegrowthanddissolutioninaqueoussolutioniii:kineticsoftransformation[j].jcrystgrowth,1997,177:248-257.
|
| [45] | kitamuram.controllingfactorofpolymorphismincrystallizationprocess[j].jcrystgrowth,2002,237:2205-2214.
|
| [46] | kakumanuv,bansala.enthalpyrelaxationstudiesofcelecoxibamorphousmixtures[j].pharmres,2002,19:1873-1878.
|
| [47] | linsy,hsuch,kewt.solid-statetransformationofdifferentgabapentinpolymorphsuponmillingandco-milling[j].intjpharm,2010,396:83-90.
|
Full-Text
|
|
Contact Us
service@oalib.com QQ:3279437679 
WhatsApp +8615387084133
|
|
